Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Schizophrenia

Free Subscription 04.05.2026 1 Br J Psychiatry 1 Brain Res 1 Cereb Cortex 2 Mol Psychiatry 2 Neuropsychopharmacology 4 Psychiatry Res 7 Psychol Med 5 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Br J Psychiatry

1. WILLIAMS R, Penington E, Gupta V, Rickett M, et al
   From early intervention in psychosis to intensive care: correlates of restrictive psychiatric practice in a national retrospective cohort study.
   Br J Psychiatry. 2026 Apr 30:1-11. doi: 10.1192/bjp.2026.10637.
   PubMed         Abstract available
   
   

   
   Brain Res

2. CASSOL G, de Souza MA, da Silva Fiorin F
   Physical exercise as a non-pharmacological adjunct in schizophrenia: Effects on molecular and biochemical parameters.
   Brain Res. 2026 Apr 25:150344. doi: 10.1016/j.brainres.2026.150344.
   PubMed         Abstract available
   
   

   
   Cereb Cortex

3. CHUNG Y, Bazmi HH, Lewis DA, Chung DW, et al
   Disrupted ErbB4 splicing with region-specific severity across the cortical visuospatial working memory network in schizophrenia.
   Cereb Cortex. 2026;36:bhag045.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

4. REICHENBERG A, Kahn RS
   Cognitive impairment preceding the onset of the first psychosis episode in schizophrenia.
   Mol Psychiatry. 2026 Apr 28. doi: 10.1038/s41380-026-03625.
   PubMed         Abstract available
   
   
5. WANG L, Xu K, Liao Y, Luo Y, et al
   Astrocytic connexin 43 hemichannel dysregulation drives prefrontal circuit dysfunction and schizophrenia-like behaviors.
   Mol Psychiatry. 2026 Apr 27. doi: 10.1038/s41380-026-03621.
   PubMed         Abstract available
   
   

   
   Neuropsychopharmacology

6. CHANG X, Bryant L, Mena Ortega S, Howes O, et al
   A frontotemporal dementia-like phenotype in schizophrenia: links to striatal dopamine and iron accumulation.
   Neuropsychopharmacology. 2026 Apr 25. doi: 10.1038/s41386-026-02426.
   PubMed         Abstract available
   
   
7. KHIN NA, Fan RH, Ge T, Klein HS, et al
   A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE study.
   Neuropsychopharmacology. 2026 Apr 24. doi: 10.1038/s41386-026-02410.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

8. LEBOVITZ JG, Kittleson AR, Sloan AF, Torregrossa LJ, et al
   Longitudinal relationships among dissociation, paranoia, and anxiety in a clinical sample of individuals with schizophrenia-spectrum conditions.
   Psychiatry Res. 2026;362:117174.
   PubMed         Abstract available
   
   
9. AHMAD I, Wang Y, Guo S, Cui L, et al
   Exploring schizophrenia-associated image-derived digital phenotypes in dual-energy X-ray densitometer scans of non-dominant distal forearm: An explainable machine-learning framework.
   Psychiatry Res. 2026;362:117186.
   PubMed         Abstract available
   
   
10. SONG X, Feng T, Lin H, Qian H, et al
    A real-world pharmacovigilance study of Xanomeline-Trospium events in the FDA adverse event reporting system (FAERS).
    Psychiatry Res. 2026;361:117162.
    PubMed         Abstract available
    
    
11. HUBBARD LA, Zhang JN, Moore RC, Depp CA, et al
    Does hearing voices make you nervous? An ecological momentary assessment investigation of momentary emotional responses to the occurrence of psychotic symptoms.
    Psychiatry Res. 2026;361:117098.
    PubMed         Abstract available
    
    

    
    Psychol Med

12. CHU MY, Zhu NJ, Li SB, Wang Y, et al
    Characterizing executive dysfunctions in patients with schizo-obsessive comorbidity: comparing schizophrenia with obsessive-compulsive disorder.
    Psychol Med. 2026;56:e116.
    PubMed         Abstract available
    
    
13. CHRISTENSEN MJ, Vernal DL, Jeppesen UN, Hjorthoj C, et al
    Treatment effect modifiers of virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: an exploratory moderator analysis of clinical and demographic characteristics in the FaceYourFears trial
    Psychol Med. 2026;56:e117.
    PubMed         Abstract available
    
    
14. ADANE AA, Dadi A, Jegnie A, Tadesse AW, et al
    Cognitive performance in offspring of parents with severe mental illness: a meta-analysis.
    Psychol Med. 2026;56:e115.
    PubMed         Abstract available
    
    
15. VAN DER WEIJDEN-GERMANN M, van Haren NEM, Meijer MN, Broer MI, et al
    Unraveling reward processing in schizophrenia and bipolar disorder: a multilevel examination of the positive valence system.
    Psychol Med. 2026;56:e112.
    PubMed         Abstract available
    
    
16. FORTE MF, Segura AG, Serra-Navarro M, Mezquida G, et al
    Cognitive reserve in non-affective first-episode psychosis: contributions of polygenic scores, early clinical features, and environment.
    Psychol Med. 2026;56:e114.
    PubMed         Abstract available
    
    
17. HU Q, Jiao X, Ding Y, Wei Y, et al
    The effects of rTMS over orbitofrontal cortex on cognitive functions in first-episode schizophrenia.
    Psychol Med. 2026;56:e119.
    PubMed         Abstract available
    
    
18. CHANG WC, Hung DP, Chen MH, Su TP, et al
    Distinct and common subcortical functional connectivity revealed across three major psychiatric disorders.
    Psychol Med. 2026;56:e109.
    PubMed         Abstract available
    
    

    
    Schizophr Res

19. VAN DER WALT K, Campbell M, Susser E, Jonker D, et al
    Distinct attentional deficits after catatonia in schizophrenia.
    Schizophr Res. 2026;294:116-123.
    PubMed         Abstract available
    
    
20. KU BS, Arrant EJ, Walker EF
    Neighborhood Characteristics and Psychosis Risk Across Development.
    Schizophr Res. 2026;294:96-98.
    PubMed        
    
    
21. HAZELTON K, Stein A, Gallardo M, Fernandes D, et al
    Trajectories of crystallized cognition over 28 years: Testing the neurodegenerative hypothesis of schizophrenia.
    Schizophr Res. 2026;294:110-115.
    PubMed         Abstract available
    
    
22. DE OLIVEIRA CA, Soares MVR, de Pinho CSN, Pinto JP, et al
    A high-resolution plasma proteomic framework for stratifying treatment resistance and ultra-resistance in schizophrenia.
    Schizophr Res. 2026;294:86-95.
    PubMed         Abstract available
    
    
23. ANTENS MHH, Kamperman AM, van Aken BC, Castelein S, et al
    Intellectual functioning and personal recovery in individuals with schizophrenia spectrum disorder.
    Schizophr Res. 2026;294:76-85.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum